Evidence map›Paper›PMID 39106285›Full record

ArticleBrain : a journal of neurology2025

Chloride deregulation and GABA depolarization in MTOR-related malformations of cortical development.

Naziha Bakouh, Reyes Castaño-Martín, Alice Metais, Emanuela Loredana Dan, Estelle Balducci, Cerina Chhuon, Joanna Lepicka, Giulia Barcia, Emma Losito, Stéphane Lourdel and 16 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Naziha BakouhTranslational Research in Neuroscience Lab, Institut Imagine, Université Paris Cité, INSERM U1163, 75015 Paris, France.
Reyes Castaño-MartínTranslational Research in Neuroscience Lab, Institut Imagine, Université Paris Cité, INSERM U1163, 75015 Paris, France.
Alice MetaisInstitute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, INSERM U1266, 75014 Paris, France.
Emanuela Loredana DanSTAR-UBB Institute, Babeş-Bolyai University, 400084 Cluj-Napoca, Romania.
Estelle BalducciDepartment of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Cerina ChhuonINSERM US24, Proteomic platform, SFR Necker, 75015 Paris, France.
Joanna LepickaINSERM US24, Proteomic platform, SFR Necker, 75015 Paris, France.
Giulia BarciaTranslational Research in Neuroscience Lab, Institut Imagine, Université Paris Cité, INSERM U1163, 75015 Paris, France.
Emma LositoDepartment of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Stéphane LourdelCordeliers Research Center, INSERM, Sorbonne University, Paris Cité University, 75006 Paris, France.
Gabrielle PlanellesCordeliers Research Center, INSERM, Sorbonne University, Paris Cité University, 75006 Paris, France.
Raul C MuresanSTAR-UBB Institute, Babeş-Bolyai University, 400084 Cluj-Napoca, Romania.
Vasile Vlad MocaSTAR-UBB Institute, Babeş-Bolyai University, 400084 Cluj-Napoca, Romania.
Anna KaminskaDepartment of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Marie BourgeoisDepartment of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Nicole ChemalyDepartment of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Yasmine RguezInstitute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, INSERM U1266, 75014 Paris, France.
Stéphane AuvinHôpital Robert Debré, Assistance Publique Hôpitaux de Paris, 75019 Paris, France.ORCID 0000-0003-3874-9749
Gilles HuberfeldInstitute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, INSERM U1266, 75014 Paris, France.
Pascale VarletInstitute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, INSERM U1266, 75014 Paris, France.
Vahid AsnafiDepartment of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Ida Chiara GuerreraINSERM US24, Proteomic platform, SFR Necker, 75015 Paris, France.
Edor KabashiTranslational Research in Neuroscience Lab, Institut Imagine, Université Paris Cité, INSERM U1163, 75015 Paris, France.ORCID 0000-0003-4118-251X
Rima NabboutTranslational Research in Neuroscience Lab, Institut Imagine, Université Paris Cité, INSERM U1163, 75015 Paris, France.
Sorana CiuraTranslational Research in Neuroscience Lab, Institut Imagine, Université Paris Cité, INSERM U1163, 75015 Paris, France.
Thomas BlauwblommeTranslational Research in Neuroscience Lab, Institut Imagine, Université Paris Cité, INSERM U1163, 75015 Paris, France.ORCID 0000-0003-4076-9642

Funding

European Commission 952096French national agency for research
6 · The paper itself

Abstract

Focal cortical dysplasia, hemimegalencephaly and cortical tubers are paediatric epileptogenic malformations of cortical development (MCDs) frequently pharmacoresistant and mostly treated surgically by the resection of epileptic cortex. Availability of cortical resection samples has allowed significant mechanistic discoveries directly from human material. Causal brain somatic or germline mutations in the AKT/PI3K/DEPDC5/MTOR genes have been identified. GABAA-mediated paradoxical depolarization, related to altered chloride (Cl-) homeostasis, has been shown to participate to ictogenesis in human paediatric MCDs. However, the link between genomic alterations and neuronal hyperexcitability is unclear. Here, we studied the post-translational interactions between the mTOR pathway and the regulation of cation-chloride cotransporters (CCCs), KCC2 and NKCC1, that are largely responsible for controlling intracellular Cl- and, ultimately, GABAergic transmission. For this study, 35 children (25 MTORopathies and 10 pseudo-controls, diagnosed by histology plus genetic profiling) were operated for drug-resistant epilepsy. Postoperative cortical tissues were recorded on a multi-electrode array to map epileptic activities. CCC expression level and phosphorylation status of the WNK1/SPAK-OSR1 pathway was measured during basal conditions and after pharmacological modulation. Direct interactions between mTOR and WNK1 pathway components were investigated by immunoprecipitation. Membranous incorporation of MCD samples in Xenopus laevis oocytes enabled measurement of the Cl- conductance and equilibrium potential for GABA. Of the 25 clinical cases, half harboured a somatic mutation in the mTOR pathway, and pS6 expression was increased in all MCD samples. Spontaneous interictal discharges were recorded in 65% of the slices. CCC expression was altered in MCDs, with a reduced KCC2/NKCC1 ratio and decreased KCC2 membranous expression. CCC expression was regulated by the WNK1/SPAK-OSR1 kinases through direct phosphorylation of Thr906 on KCC2, which was reversed by WNK1 and SPAK antagonists (N-ethylmaleimide and staurosporine). The mSIN1 subunit of MTORC2 was found to interact with SPAK-OSR1 and WNK1. Interactions between these key epileptogenic pathways could be reversed by the mTOR-specific antagonist rapamycin, leading to a dephosphorylation of CCCs and recovery of the KCC2/NKCC1 ratio. The functional effect of such recovery was validated by the restoration of the depolarizing shift in the equilibrium potential for GABA by rapamycin, measured after incorporation of MCD membranes into X. laevis oocytes, in line with a re-establishment of normal Cl- reversal potential. Our study deciphers a protein interaction network through a phosphorylation cascade between MTOR and WNK1/SPAK-OSR1 leading to deregulation of chloride cotransporters, increased neuronal Cl- levels and GABAA dysfunction in malformations of cortical development, linking genomic defects and functional effects and paving the way to target epilepsy therapy.

Indexed as

Chloridesgamma-Aminobutyric AcidMalformations of Cortical DevelopmentTOR Serine-Threonine KinasesAdolescentAnimalsCerebral CortexChildChild, PreschoolFemaleHumansInfantK Cl- CotransportersMaleSolute Carrier Family 12, Member 2SymportersChloridesgamma-Aminobutyric AcidK Cl- CotransportersMTOR protein, humanSLC12A2 protein, humanSolute Carrier Family 12, Member 2SymportersTOR Serine-Threonine KinasesWNK Lysine-Deficient Protein Kinase 1epilepsyGABAA receptormalformation of cortical dysplasiamTORrapamycinWNK1/SPAK-OSR1

Identifiers

PMID39106285
PMCPMC11788215

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.